TWO SIGMA ADVISERS, LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 145 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.4%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,505,574
+58.1%
1,536,300
+124.3%
0.00%
+100.0%
Q2 2023$952,194
-30.1%
685,032
-20.1%
0.00%
-50.0%
Q1 2023$1,362,948
-84.6%
857,200
-39.5%
0.00%
-84.0%
Q4 2022$8,821,680
+21.4%
1,416,000
+30.6%
0.02%
+19.0%
Q3 2022$7,265,000
+8447.1%
1,084,300
+7991.8%
0.02%
Q2 2022$85,000
-96.0%
13,400
-77.1%
0.00%
-100.0%
Q3 2019$2,141,000
-70.1%
58,400
-62.0%
0.01%
-72.2%
Q2 2019$7,155,000
+164.0%
153,800
+127.9%
0.02%
+157.1%
Q1 2019$2,710,000
+26.2%
67,500
+44.5%
0.01%
+16.7%
Q4 2018$2,148,000
+39.4%
46,700
+119.2%
0.01%
+50.0%
Q1 2018$1,541,000
-2.5%
21,300
-11.2%
0.00%0.0%
Q4 2017$1,580,000
+112.9%
24,000
+62.2%
0.00%
+100.0%
Q3 2017$742,000
-85.8%
14,800
-76.8%
0.00%
-95.0%
Q2 2015$5,213,000
+151.8%
63,759
+185.2%
0.04%
+150.0%
Q1 2015$2,070,00022,3590.02%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2015
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders